The White House has urged U.S. drug manufacturers who currently have FDA-approved opioid overdose reversal medication products to increase access and affordability of these life-saving medicines to the public.
The call was made at a meeting convened by the Office of National Drug Control Policy Director Dr. Rahul Gupta. White House Domestic Policy Council Advisor Neera Tanden, U.S. Assistant Secretary for Health Admiral Rachel Levine, and U.S. Assistant Secretary for Mental Health and Substance Use Dr. Miriam E. Delphin-Rittmon also attended the meeting.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
by Joji Xavier
For comments and feedback: contact editorial@rttnews.com